Back ground
Atherosclerosis is a chronic inflammatory process involving the arterial endothelium leading to stenosis, contributing to the pathophysiology of intermittent claudication (IC). Cardiovascular risk factors enhance the progression of the inflammatory process leading to increased morbidity and mortality at least 50% at 10 years. Patients with IC are at high risk of coronary and cerebrovascular events. The systemic inflammatory response damages the endothelium, initiating release of several vasoactive mediators leading to further damage. Several studies have shown the beneficial effect of supervised exercise (SE) on walking distance and general cardiovascular health. Furthermore, the effect of exercise on inflammatory and noninflammatory markers has been widely studied .
Aim
The aim of this systematic review is to examine the effect of SE on inflammatory and noninflammatory biomarkers in patients with IC. 
Methods
A comprehensive search of the published literature was conducted in accordance with PRISMA guidelines (11). Cochrane, Embase and MEDLINE databases were systematically searched using the Ovid interface for articles published from 1949 to 2016 reporting the impact of supervised exercise of 2 weeks duration or more on biomarker levels in patients with intermittent claudication. The following key words were used in the mesh search: ('lower limb arterial disease' OR 'ischemia' OR 'extremities' OR 'IC leg' OR 'PAD' OR 'PVD', OR 'AOD') AND ('metabolome' OR 'metabonomics' OR 'proteonomics' OR 'biomarker') AND ('exercise therapy' OR 'exercise' OR 'walking' OR 'exercise test' OR 'physical exertion'). Inclusion criteria SE for a minimum of 2 weeks duration Patients with IC symptoms proven of peripheral arterial disease aetiology Human studies Exclusion criteria SE for less than 2 weeks duration Non-human animal studies Review articles 
